Long-Acting Injectable PrEP is Here: Implementation and Capacity Building Opportunities

Long-Acting Injectable PrEP and HIV Treatment PodcastПодробнее

Making PrEP accessible: Updates on long-acting injectable optionsПодробнее

Long-Acting Injectable Cabotegravir: the Future of HIV PrEP?Подробнее

Long-Acting Injectable PrEP and HIV Treatment MicrolearningПодробнее

Long-acting Injectable HIV Treatment Implementation and Coordination (20674)Подробнее

Health disparities and the rollout of long-acting injectable ART and PrEPПодробнее

Preparing for Pharmacy-based Delivery of Long-Acting Injectable HIV AntiretroviralsПодробнее

Let’s Talk About PrEP – David Malebranche, MD, MPHПодробнее

Mini Lecture Series: Long-Acting, Injectable Cabotegravir-Rilpivirine (CAB-RPV)Подробнее

Louisville doctors praise new injectable HIV prevention drugПодробнее

Demedicalizing Long-Acting PrEP/ART, Rupa Patel, MD, MPHПодробнее

Implementation of Long-Acting PrEP: Case-Based Panel Discussion With CliniciansПодробнее

Long-acting PrEP for MSM and TGW-Challenges and Opportunities - Beatriz Grinsztejn, MD, PhDПодробнее

Advanced PrEP Implementation in a Primary Care SettingПодробнее

Does PrEP really work?Подробнее

Spotlight on New PrEP Tools and Data: From R&D to AccessПодробнее

New injectable PrEP JUST released!Подробнее

“Building Clinical Workforce Capacity to Deliver PrEP”Подробнее

JIAS Symposium - Advancing Use of Long-Acting HIV Treatment and Prevention RegimensПодробнее